多肽偶联药物是精准肿瘤治疗领域中极具前景的创新药物类型之一。PDCs与抗体偶联药物（ADCs）基于相同原理，即通过靶向载体递送细胞毒性药物。不同之处在于，PDCs采用短小、可合成的肽链替代大型抗体。这些细胞靶向肽（CTPs）分子量仅为数千道尔顿，赋予 ...

Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC - - Sutro has selected PTK7 as the target for its initial dual-payload candidate, STRO-227 - - Investor ...

To help bridge that gap, Morrisville-based Kymanox Corporation has entered into a non-exclusive collaboration with Jabil Inc., which is based in St. Petersburg, Florida, to support companies ...

“Our investment in the Durham laboratory services facility reflects Alcami’s dedication to scientific excellence, innovation, and operational agility,” said Katie Schlipp, President of Laboratory ...

This case study demonstrates how advanced NMR spectroscopy enables high-resolution structural characterization of exenatide.

Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...

We applied swim flume-mediated exercise during zebrafish caudal fin regeneration to explore mechanical loading impacts on a robust model of organ regeneration. Exercise initiated during but not after ...